This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004:15 Suppl 4:iv223-7.

doi: 10.1093/annonc/mdh930.

Molecular targeting: targeting angiogenesis in solid tumors

J-C Soria¹, J Fayette, J-P Armand

Affiliations

PMID: 15477311
DOI: 10.1093/annonc/mdh930

Free article

Review

Molecular targeting: targeting angiogenesis in solid tumors

J-C Soria et al. Ann Oncol. 2004.

Free article

. 2004:15 Suppl 4:iv223-7.

doi: 10.1093/annonc/mdh930.

Authors

J-C Soria¹, J Fayette, J-P Armand

Affiliation

¹ Institut Gustave Roussy, Département de Médecine, Villejuif, France.

PMID: 15477311
DOI: 10.1093/annonc/mdh930

No abstract available

PubMed Disclaimer

Similar articles

Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y, Adjei AA. Zhao Y, et al. Oncologist. 2015 Jun;20(6):660-73. doi: 10.1634/theoncologist.2014-0465. Epub 2015 May 22. Oncologist. 2015. PMID: 26001391 Free PMC article. Review.
Bevacizumab pharmacogenetics in tumor treatment: still looking for the right pieces of the puzzle.
Bocci G, Loupakis F. Bocci G, et al. Pharmacogenomics. 2011 Aug;12(8):1077-80. doi: 10.2217/pgs.11.75. Pharmacogenomics. 2011. PMID: 21843059 No abstract available.
Editorial: Angiogenesis agents.
Marcinkiewicz C. Marcinkiewicz C. Curr Pharm Des. 2007;13(35):3543-4. doi: 10.2174/138161207782794112. Curr Pharm Des. 2007. PMID: 18220790 No abstract available.
Antiangiogenic therapies targeting the vascular endothelia growth factor signaling system.
Tie J, Desai J. Tie J, et al. Crit Rev Oncog. 2012;17(1):51-67. doi: 10.1615/critrevoncog.v17.i1.50. Crit Rev Oncog. 2012. PMID: 22471664 Review.
Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.
Bikfalvi A, Bicknell R. Bikfalvi A, et al. Trends Pharmacol Sci. 2002 Dec;23(12):576-82. doi: 10.1016/s0165-6147(02)02109-0. Trends Pharmacol Sci. 2002. PMID: 12457776 Review.

See all similar articles

Cited by

Molecular imaging probes for diagnosis and therapy evaluation of breast cancer.
Meng Q, Li Z. Meng Q, et al. Int J Biomed Imaging. 2013;2013:230487. doi: 10.1155/2013/230487. Epub 2013 Feb 26. Int J Biomed Imaging. 2013. PMID: 23533377 Free PMC article.
Targeted transport of 125I-labeled antibody to GFAP and AMVB1 in an experimental rat model of C6 glioma.
Chekhonin VP, Baklaushev VP, Yusubalieva GM, Gurina OI. Chekhonin VP, et al. J Neuroimmune Pharmacol. 2009 Mar;4(1):28-34. doi: 10.1007/s11481-008-9123-5. Epub 2008 Sep 4. J Neuroimmune Pharmacol. 2009. PMID: 18770045
Non-Markovian Population Dynamics: Does it Help to Optimize the Chemotherapeutic Strategy?
Kuznetsov DA, Roumiantsev SA, Fallahi M, Amirshahi N, Makarov AV, Kardashova KS. Kuznetsov DA, et al. Int J Biomed Sci. 2010 Mar;6(1):71-6. Int J Biomed Sci. 2010. PMID: 23675179 Free PMC article.
Suppression of vascular endothelial growth factor via siRNA interference modulates the biological behavior of human nasopharyngeal carcinoma cells.
Zhou HB, Yin YF, Hu Y, Li X, Zou LY, Li YJ, Gu Y, Ou BQ, Fu J, Du JH, Wu G. Zhou HB, et al. Jpn J Radiol. 2011 Nov;29(9):615-22. doi: 10.1007/s11604-011-0603-9. Epub 2011 Sep 29. Jpn J Radiol. 2011. PMID: 21956366
A first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and other advanced solid tumours.
El Helali A, Plummer R, Jayson GC, Coyle VM, Drew Y, Mescallado N, Harris N, Clamp AR, McCann J, Swaisland H, Kennedy RD, Cranston AN, Wilson RH. El Helali A, et al. Br J Cancer. 2022 Jul;127(1):92-101. doi: 10.1038/s41416-022-01780-z. Epub 2022 May 14. Br J Cancer. 2022. PMID: 35568736 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database